Insider Trading Alert - CRL, GLW And RVBD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 13, 2014, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,704.50 to $121,177,500.00.

Highlighted Stocks Traded by Insiders:

Charles River Laboratories International In (CRL) - FREE Research Report

Wallman Richard F, who is Director at Charles River Laboratories International In, sold 3,240 shares at $58.20 on Aug. 13, 2014. Following this transaction, the Director owned 16,180 shares meaning that the stake was reduced by 16.68% with the 3,240-share transaction.

The shares most recently traded at $58.81, up $0.61, or 1.04% since the insider transaction. Historical insider transactions for Charles River Laboratories International In go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 7,220
  • 24-Week # shares sold: 52,515

The average volume for Charles River Laboratories International In has been 416,700 shares per day over the past 30 days. Charles River Laboratories International In has a market cap of $2.7 billion and is part of the health care sector and health services industry. Shares are up 10.48% year-to-date as of the close of trading on Wednesday.

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. The company has a P/E ratio of 23.8. Currently, there are 5 analysts who rate Charles River Laboratories International In a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRL - FREE

TheStreet Quant Ratings rates Charles River Laboratories International In as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Charles River Laboratories International In Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Corning (GLW) - FREE Research Report

McRae Lawrence D, who is Executive Vice President at Corning, sold 12,000 shares at $20.17 on Aug. 13, 2014. Following this transaction, the Executive Vice President owned 82,479 shares meaning that the stake was reduced by 12.7% with the 12,000-share transaction.

The shares most recently traded at $20.32, up $0.15, or 0.74% since the insider transaction. Historical insider transactions for Corning go as follows:

  • 4-Week # shares sold: 70,102
  • 12-Week # shares sold: 81,129
  • 24-Week # shares sold: 81,129

The average volume for Corning has been 7.5 million shares per day over the past 30 days. Corning has a market cap of $26.1 billion and is part of the technology sector and electronics industry. Shares are up 14.03% year-to-date as of the close of trading on Wednesday.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The stock currently has a dividend yield of 1.98%. The company has a P/E ratio of 22.4. Currently, there are 6 analysts who rate Corning a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GLW - FREE

TheStreet Quant Ratings rates Corning as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Corning Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Riverbed Technology (RVBD) - FREE Research Report

Wolford Eric, who is Director at Riverbed Technology, sold 13,095 shares at $18.19 on Aug. 13, 2014. Following this transaction, the Director owned 46,300 shares meaning that the stake was reduced by 22.05% with the 13,095-share transaction.

The shares most recently traded at $18.32, up $0.13, or 0.73% since the insider transaction. Historical insider transactions for Riverbed Technology go as follows:

  • 4-Week # shares sold: 16,900
  • 12-Week # shares sold: 33,800
  • 24-Week # shares sold: 38,800

The average volume for Riverbed Technology has been 1.3 million shares per day over the past 30 days. Riverbed Technology has a market cap of $2.9 billion and is part of the technology sector and computer software & services industry. Shares are up 1.02% year-to-date as of the close of trading on Wednesday.

Riverbed Technology, Inc. provides application performance infrastructure solutions in the United States and internationally. It offers Steelhead products, a suite of WAN optimization products delivered on virtual appliances, software, and public cloud environments. The company has a P/E ratio of 139.5. Currently, there are 3 analysts who rate Riverbed Technology a buy, no analysts rate it a sell, and 21 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RVBD - FREE

TheStreet Quant Ratings rates Riverbed Technology as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Riverbed Technology Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists